CanSino Biologics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CASBF research report →
Price Chart
About the company
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.
- CEO
- Xue Feng Yu
- IPO
- 2020
- Employees
- 1,134
- HQ
- Tianjin, TI, CN
Get TickerSpark's AI analysis on CASBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.36B
- P/E
- 2162.08
- Fwd P/E
- 15.06
- PEG
- -76.17
- P/S
- 10.49
- P/B
- 3.23
- EV/EBITDA
- 64.95
- Div Yield
- 0.00%
- Gross Margin
- 75.00%
- Op Margin
- -0.16%
- Net Margin
- -0.09%
- ROE
- -0.02%
- ROIC
- 0.01%
Latest fiscal year · YoY change
- Revenue
- $1.03B+25.1%
- Gross Profit
- $681.87M+17.5%
- Op Income
- $-113,129,268
- Net Income
- $27.15M+107.2%
- EPS
- $0.11+107.2%
- OCF Growth
- +119.2%
- FCF Growth
- +75.6%
- 52W High
- $6.99
- 52W Low
- $2.60
- 50D MA
- $2.96
- 200D MA
- $3.97
- Beta
- 1.22
- RSI (14)
- 95
- Avg Volume
- 66
No earnings-call transcripts are available for CASBF yet.
- Free Float
- 48.6%
- Shares Outstanding
- 349.31M
- Float Shares
- 169.60M
Our CASBF coverage
Recent articles, reports, and earnings notes.
No research on CASBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CASBF report →CanSinoBIO at WGS 2026: Accelerating Global Access to Innovative Vaccines
prnewswire.com · Feb 9
CanSino Biologics CEO on earnings, business outlook, and international partnerships
youtube.com · Apr 30
Riding Covid Vaccine Highs, CanSino Plans Swiss Listing
seekingalpha.com · Jan 17
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
investorplace.com · Nov 2
China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
reuters.com · Aug 28
COVID shot drives CanSinoBIO's first six-month profit since at least 2019
reuters.com · Aug 27
Pandemic Accelerates China's Drive Into mRNA Treatments
seekingalpha.com · Jun 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.